ATP-competitive and allosteric inhibitors induce differential conformational changes at the autoinhibitory interface of Akt1

• DOI: 10.1016/j.str.2023.01.007
• Publication Date: 2023-02-08T15:36:40Z
• Authors: Alexandria L. Shaw; Matthew A.H. Parson; Linda Truebestein; Meredith L. Jenkins; Thomas A. Leonard; John E. Burke
• Keywords: Pleckstrin homology domain; AKT2; Proto-Oncogene Proteins c-akt

Akt is a master regulator of pro-growth signaling in the cell. Akt is activated by phosphoinositides that disrupt the autoinhibitory interface between the kinase and pleckstrin homology (PH) domains and then is phosphorylated at T308 and S473. Akt hyperactivation is oncogenic, which has spurred development of potent and selective inhibitors as therapeutics. Using hydrogen deuterium exchange mass spectrometry (HDX-MS), we interrogated the conformational changes upon binding Akt ATP-competitive and allosteric inhibitors. We compared inhibitors against three different states of Akt1. The allosteric inhibitor caused substantive conformational changes and restricts membrane binding. ATP-competitive inhibitors caused extensive allosteric conformational changes, altering the autoinhibitory interface and leading to increased membrane binding, suggesting that the PH domain is more accessible for membrane binding. This work provides unique insight into the autoinhibitory conformation of the PH and kinase domain and conformational changes induced by Akt inhibitors and has important implications for the design of Akt targeted therapeutics.